https://www.selleckchem.com/JAK.html
BACKGROUND Cancer is the second leading cause of mortality worldwide. Despite of several advances made in the treatment strategies, cure for cancer remains still a challenge. Currently used treatment modalities pose several side effects and remain ineffective in the later stages. Thiazolidinediones (TZDs) have been shown to possess anti-cancer activity in several in vitro models. OBJECTIVES The objectives of this study were to assess the effect of novel synthesized thiazolidinedione derivatives on three selected cancer cell lines viz., human breast
Like
Comment
Share
